The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer’s Disease Genetics
Open accessAbstract
Alzheimer's disease (AD) is a debilitating, chronic neurodegenerative disease. Genetic studies involving genome-wide association studies (GWAS) and meta-analysis have discovered numerous genomic loci associated with AD; however, the causal genes and variants remain unidentified in most loci. Integration of GWAS signals with epigenomic annotations has demonstrated that AD risk variants are enriched in myeloid-specific enhancers, implicating myeloid cells in AD etiology. AD risk variants in these regulatory elements modify disease susceptibility by regulating the expression of genes that play crucial roles in microglial phagocytosis. Several of these AD risk genes are specifically expressed in myeloid cells, whereas others are ubiquitously expressed but are regulated by AD risk variants within myeloid enhancers in a cell type-specific manner. We discuss the impact of established AD risk variants on microglial phagocytosis and debris processing via the endolysosomal system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under normal conditions, they help maintain homeostasis by providing neurotrophic support and clearing harmful substances, such as amyloid plaques, through phagocytosis [8, 9, 10].”
From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As previously reported, we found that Cass4 is predominantly expressed by microglia in the brain (Fig. S1 G; Lee et al., 2023; Podlesny-Drabiniok et al., 2020).”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Podlesny-Drabiniok et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of the brain-resident cell types, Cass4 appears to be ex pressed only by microglia (Lee et al., 2023; Podlesny-Drabiniok et al., 2020; Zhang et al., 2014).”
From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Podlesny-Drabiniok et al., 2020
Experimental — accuracy not yet measuredIn the citing paper
“The phagocytic activity of microglia is crucial for the removal of Aβ,94 tau,95 and α-synuclein.96”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [94]
In the citing paper
“However, microglial phagocytic activity becomes dysfunctional during aging and neurodegenerative diseases, resulting in the gradual accumulation of toxic compounds and cognitive decline.93,94”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [94]
In the citing paper
“A core function of microglia is the efficient recognition and phagocytic clearance of protein aggregates and cellular debris without damaging surrounding tissue to maintain CNS homeostasis.93,94”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationKrasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 211
Ding, Y., Li, S.-Y., Lv, W., Li, L., Zhang, H., Zhang, Z., Zhang, Y.-J., Zhang, Z., & Lu, X.-W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04255-9 · Cited by 9
Tau aggregation and its relation to selected forms of neuronal cell death.
Tolkovsky, A. M., & Spillantini, M. G. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.80530 · Cited by 9
Causal ALS genes impact the MHC class II antigen presentation pathway
Chi, B., Öztürk, M. M., Paraggio, C. L., Leonard, C. E., Sanita, M. E., Dastpak, M., O’Connell, J. D., Coady, J. A., Zhang, J., Gygi, S. P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305756120 · Cited by 8
Huang, C.-C., Tsai, S., Liu, S., Yeh, M.-C., Hung, H., Lee, C.-W., Cheng, C., Hsu, P., & Kuo, Y.-M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s481101 · Cited by 9
Expression of anti-amyloid CARs in microglia promotes efficient and selective phagocytosis of Aβ1‒42
Heiss, C. N., Riise, R. E., Hanse, E., Fruhwürth, S., Zetterberg, H., & Björefeldt, A. (2025) · Gene Therapy · doi:10.1038/s41434-025-00534-9 · Cited by 9
DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease
Yang, R., Wang, L., Li, Y., Zhu, J., Wang, J., Schlessinger, D., & Sima, J. (2025) · Science Advances · doi:10.1126/sciadv.adz2099 · Cited by 8
Human iPSC‐Derived Microglia Integrate Into Cerebral Organoids and Assume an In Vivo‐Like Phenotype
Wogram, E., Sümpelmann, F., Khalil, A. S., Flamier, A., Fu, D., Bell, G. W., & Jaenisch, R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70281 · Cited by 8
Pomilio, A. B., Vitale, A. A., & Lazarowski, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220413094918 · Cited by 9
Ng, C. A. S., Biran, L. P., Galvano, E., Mandelblatt, J. S., Vicini, S., & Rebeck, G. W. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105915 · Cited by 9
Application of Caenorhabditis elegans in the evaluation of food nutrition: A review
Li, Q., Xiao, M., Li, N., Cai, W., Zhao, C., Liu, B., & Zeng, F. (2023) · eFood · doi:10.1002/efd2.68 · Cited by 8
Yang, S. S., Simtchouk, S., Gibon, J., & Klegeris, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289169 · Cited by 7
The human microglia responsome: a resource for microglia states in health and disease
Snijders, G. J. L., Lopes, K. D. P., Sneeboer, M. A. M., Muller, B. Z., Gigase, F. A. J., D’Urso, D., Vialle, R. A., Missall, R. D., Kübler, R., Raj, T., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106095 · Cited by 9
Gu, D., Wang, L., Zhang, N., Wang, H., & Yu, X. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02750-9 · Cited by 9
Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease
Signal, B., Suárez, T. G. P., Taberlay, P. C., & Woodhouse, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106284 · Cited by 8
Davis, G. H., Zaya, A., & Pearce, M. M. P. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1256-23.2024 · Cited by 7
Arber, C., Casey, J. M., Crawford, S., Rambarack, N., Yaman, Ü., Wiethoff, S., Augustin, E., Piers, T. M., Price, M., Rostagno, A. A., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02820-z · Cited by 8
Turner, A. K., Shaw, B. C., Simpson, J. F., & Estus, S. (2022) · Genes · doi:10.3390/genes13091607 · Cited by 7
Coupling of Alzheimer’s Disease Genetic Risk Factors with Viral Susceptibility and Inflammation
Cao, C., Fu, G., Xu, R., & Li, N. (2023) · Aging and Disease · doi:10.14336/ad.2023.1017 · Cited by 8
Michalski, C., & Wen, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1291115 · Cited by 7
Podlesny‐Drabiniok, A., Romero‐Molina, C., Patel, T., See, W. Y., Liu, Y., Marcora, E. M., & Goate, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115909 · Cited by 7
Self-citationMesenchymal stem cells and secretome as modulators of neuroinflammation in neurological disorders
Yao, D., Nie, L., Liu, X., Wu, X., Tang, Y., Pan, C., Chen, S., Chen, D., Wu, D., Nie, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08052-x · Cited by 6
Philippi, S. M., Kailash, B. P., Raj, T., & Castellano, J. M. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52250 · Cited by 7
Current methods for the microglia isolation: Overview and comparative analysis of approaches
Akhmetzyanova, E. R., Rizvanov, A. A., & Mukhamedshina, Y. O. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03853-8 · Cited by 7
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Shekho, D., Mishra, R., Kamal, R., Bhatia, R., & Awasthi, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02923-6 · Cited by 6
Podleśny-Drabiniok, A., Novikova, G., Liu, Y.-Y., Dunst, J., Temizer, R., Giannarelli, C., Marro, S. G., Kreslavsky, T., Marcora, E., & Goate, A. (2023) · bioRxiv · doi:10.1101/2023.02.13.528372 · Cited by 5
Self-citationWang, Y., Li, Y., Zhou, L., Yuan, Y., Liu, C., Zeng, Z., Chen, Y., He, Q., & Wu, Z. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1568337 · Cited by 5
Popa, A. E., Popa, E., Dramba, T., Coman, A. E., Poroch, M., Ungureanu, M. I., Bacușcă, A. I., Slănină, A. M., Bacoanu, G., & Poroch, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311383 · Cited by 7
Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4
Nolt, G. L., Golden, L. R., Thorpe, S. P., Funnell, J. L., Stephens, I. O., Hernandez, G., MacLean, S. M., Lucido, C. C., Brock, C. R., Pallerla, A. V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03639-5 · Cited by 5
Cai, L., Zhang, Y., Li, J., Hu, L., Meng, Q., Shao, J., Deng, H., Liu, Y., Liu, J., Liang, Y., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08557-9 · Cited by 5
Programmable CAR immunotherapies for neurodegenerative proteinopathies
Pesce, G., Estivill-Alonso, M., & Ventura, S. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.02.009 · Cited by 5
Nassrallah, W. B., Li, H. R., Irani, L., Wijesinghe, P., Hogg, P. W., Hui, L., Oh, J., Mackenzie, I. R., Hirsch‐Reinshagen, V., Hsiung, G. R., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01898-6 · Cited by 9
Miao, X., Yue, W., Wang, J., Chen, J., Qiu, L., Paerhati, H., Zhou, Q., Li, P., Wu, A., & Zhang, M. (2025) · Current Neuropharmacology · doi:10.2174/011570159x417328250908080404 · Cited by 6
Perivascular SPP1 Mediates Microglial Engulfment of Synapses in Alzheimer’s Disease ModelsPreprint
Schepper, S. D., Ge, J. Z., Crowley, G., Ferreira, L. S. S., Garceau, D. T., Toomey, C. E., Sokolova, D., Childs, T., Lashley, T., Burden, J. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.486547 · Cited by 5
Functional border-associated macrophages limit Alzheimer’s Disease progressionPreprint
Adler, D. I., Pinheiro-Rosa, N., Millet, A., Gajic, Z. Z., Cheng, E., Gamallo‐Lana, B., Morizawa, Y. M., Klann, E., Gan, W., Mar, A. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.703045 · Cited by 8
Pérez-Boyero, D., de la Mata, A., Castillo-Sanchez, J., Reverte, I., Yanguas‐Casás, N., Ávila-Zarza, C. A., Valero, J., Alonso, J. R., Arévalo, M., Ragozzino, D., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106248 · Cited by 4
Katola, F. O., Adana, M. Y., & Olajide, O. A. (2024) · Inflammation Research · doi:10.1007/s00011-024-01952-y · Cited by 4
Pesti, I., Varga, V., Qorri, E., Frank, R., Kata, D., Vinga, K., Szarvas, P. A., Menyhárt, Á., Gulya, K., Bari, F., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70060 · Cited by 5
Song, Y.-Z., Li, Y., Dong, Q., Zhang, Y. L., Wang, J., Han, X., Mao, M., Dong, Y., Tang, S. H., Hou, T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251385261 · Cited by 4
Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
Chen, D., Li, J., Liu, H., Liu, X., Zhang, C., Luo, H., Wei, Y., Xi, Y., Liang, H., & Zhang, Q. (2023) · Genes · doi:10.3390/genes14071322 · Cited by 4
Rueda‐Carrasco, J., Sokolova, D., Lee, S., Childs, T., Jurčáková, N., Schepper, S. D., Ge, J. Z., Lachica, J., Toomey, C. E., Freeman, O. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.486424 · Cited by 4
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1598611/v1 · Cited by 4
Cao, M., Zhang, Y., Li, Y., Zhang, X., & Ma, M. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.3.4 · Cited by 3
FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer's disease mouse model
Hung, W.-C., Sun, W., Su, T., Lee, Y.-J., & Cheng, I. H.-J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115357 · Cited by 6
Zhou, Z., Deng, Z., Huang, Y., Chen, J., Yang, J. H., & Cao, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116636 · Cited by 4
MerTK-triggered TGFβ1 autocrine signal regulates microglial response to neurodegeneration
Huang, Y., Deng, Z., Zhou, Z., Fu, K., Liu, F., Zhang, H., Chen, J., Yang, J. H., & Cao, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-69189-3 · Cited by 4
Lan, Z., Liu, H., Huang, C., Li, J. R., Dai, Z., Yuan, Y. Z., He, C., Qin, S., & Su, Z. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106170 · Cited by 4
Perivascular signals drive microglial appetite
O’Brien, C. A., & Bennett, F. C. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01256-0 · Cited by 3
Microglial amyloid beta clearance is driven by PIEZO1 channelsPreprint
Konttinen, H., Sitnikova, V., Ishchenko, Y., Shakirzyanova, A., Giudice, L., Ugidos, I. F., Gómez‐Budia, M., Korvenlaita, N., Ohtonen, S., Belaya, I., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.18.484831 · Cited by 3
Neuro‐immune interactions in health and disease: Insights from FENS‐Hertie 2022 Winter School
Binder, L. B., da Rosa, P. B., de Sousa, B. M., Chagas, L. D. S., Dubljević, O., Martineau, F. S., Mottarlini, F., Castany, S., Morton, L., Krstanović, F., et al. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16262 · Cited by 2
Czapski, G. A., Matuszewska, M., Cieślik, M., & Strosznajder, J. B. (2024) · Folia Neuropathologica · doi:10.5114/fn.2024.138140 · Cited by 2
Wang, H., Yang, J., Sun, Z., Nie, Y., & He, Y. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.07.012 · Cited by 2
Immunity in Parkinson's disease – The role of innate responses
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578716 · Cited by 4
Brelstaff, J., Mason, M., Katsinelos, T., McEwan, W. A., Ghetti, B. F., Tolkovsky, A. M., & Spillantini, M. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.26.433088 · Cited by 2
The autophagy proteome in the brain
Ito‐Silva, V. I., Smith, B. J., & Martins‐de‐Souza, D. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16204 · Cited by 2
Fukuda, M., Lin, G. R., Liu, Y., Hammel, G., Kizer, A., Ayazi, M., Joshi, S., Liu, Y., Ren, Y., & Guan, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22223 · Cited by 1
A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits
Zhou, Y., Su, T., Yuan, M., Li, W., Zhou, Y., Kou, J., Chang, J.-S., Liu, D., Chen, L., Zhan, K., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251372587 · Cited by 1
Identification of common human TMEM173 genotypes associated with Alzheimer's disease
Usher, M. R., Aybar-Torres, A., & Jin, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251396973 · Cited by 1
Beta‐Arrestin2‐Biased Activation by Pilocarpine Suppresses Microglial Inflammatory Response
Xie, Y. J., Wang, K., Wang, S., Yao, Y., Wang, D., Hongzhuan, C. H. E. N., Zhao, L., & Xu, J. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70334 · Cited by 1
Roles of Glia in Synapse Nano-organization
Choi, Y., & Chung, W. (2026) · Advances in neurobiology · doi:10.1007/978-3-032-12594-1_11 · Cited by 1
Gaudet, A. D., & Fonken, L. K. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.01.002 · Cited by 3
Hirota, Y., Yamamoto, J., Takatori, S., Sakakibara, Y., Takei, K., 佐治多美子, Sekiya, M., Tomita, T., & Iijima, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00032-1 · Cited by 1
Wei, Y., Ming-li, S. U., Ren, D.-L., Zhang, X., Zhu, T., & Yan, X. (2024) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2024.04.004 · Cited by 1
Functional Glial Activation Mediates Phenotypic Effects of APOEɛ4 and Sex in Alzheimer’s Disease
Lane, R. M., Li, D. X., & Darreh‐Shori, T. (2024) · Neuroglia · doi:10.3390/neuroglia5030022 · Cited by 2
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.16.464454 · Cited by 1
Litke, R. R., Vicari, J. M., Huang, B. T., Shapiro, L. R., Roh, K.-H., Silver, A. E., Talreja, P., Palacios, N., Yoon, Y., Kellner, C. P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.12.544352 · Cited by 1
Mattei, D., Ivanov, A., Hammer, J., Ugursu, B., Schalbetter, S. M., Richetto, J., Weber‐Stadlbauer, U., Mueller, F. S., Scarborough, J., Wolf, S. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.17.567571 · Cited by 1
Glial activation mediates phenotypic effects of APOEε4 and sex in Alzheimer’s diseasePreprint
Lane, R. M., Li, D., & Darreh‐Shori, T. (2024) · medRxiv · doi:10.1101/2024.03.08.24303882 · Cited by 1
Inflammatory Signatures of Microglia in the Mouse Model of Corticosterone-Induced DepressionPreprint
Zhao, Y., Huang, Y., Cao, Y., & Yang, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.608928 · Cited by 1
Pesti, I., Varga, V., Qorri, E., Frank, R., Kata, D., Vinga, K., Szarvas, P. A., Menyhárt, Á., Gulya, K., Bari, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.11.623031 · Cited by 1
APOE4 alters the lipid droplet proteome and modulates droplet dynamicsPreprint
Friday, C. M., Stephens, I. O., Smith, C. T., Lee, S., Satish, D., Devanney, N. A., Cohen, S., Morganti, J. M., Gordon, S. M., & Johnson, L. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628710 · Cited by 1
Youth-associated protein TIMP2 alters microglial state and function in the context of agingPreprint
Hemmer, B. M., Ferreira, A. C., Philippi, S. M., Petridis, S. F., Phan, A., & Castellano, J. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.20.655226 · Cited by 1
A validated method for banking mixed glial cultures that yield responsive microgliaPreprint
Sturno, A. M., Hassell, J. E., Baker, K. M., Potter, G. J., & Bruce, K. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.13.693524 · Cited by 1
Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease
Kim, B., Wang, S. S., Kim, J. R., & Kim, J. (2026) · BioEssays · doi:10.1002/bies.70186
“Under normal conditions, they help maintain homeostasis by providing neurotrophic support and clearing harmful substances, such as amyloid plaques, through phagocytosis [8–10].”
Sato, K., Watamura, N., Fujioka, R., Mihira, N., Sekiguchi, M., Nagata, K., Ohshima, T., Saito, T., Saido, T. C., & Sasaguri, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.30.442122
Three ALS genes regulate expression of the MHC class II antigen presentation pathwayPreprint
Chi, B., Öztürk, M. M., Paraggio, C. L., Leonard, C. E., Sanita, M. E., Dastpak, M., O’Connell, J. D., Coady, J. A., Zhang, J., Gygi, S. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.11.489680
Multiomic Phagosome Profiling as a New Tool to Study Human Microglia BiologyPreprint
Wogram, E., Sümpelmann, F., Dong, W., Rawat, E. S., Fernández-Maestre, I., Fu, D., Braswell, B., Khalil, A. S., Buescher, J. M., Borner, G. H. H., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4585843
Sobrecarga de cobre y enfermedad de Alzheimer, búsqueda de posibles blancos terapéuticos
Zubillaga, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165188
Yaman, Ü., Banks, G. T., Gustavsson, E. K., Mumford, P., Magusali, N., Taso, O. S., Macpherson, H. L., Carmona, S., Murray, M., Bains, R. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.10.607237
Neurovirology and Brain Health—A Microglial Perspective
Biswas, A. K., & Sarma, J. D. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_7
Podleśny-Drabiniok, A., Romero-Molina, C., Patel, T., Wen, Y.-S., Liu, Y.-Y., Marcora, E., & Goate, A. (2024) · bioRxiv · doi:10.1101/2024.10.24.619910 · Cited by 7
Self-citationMackie, E. C., Cheng, C.-H., Alibrio, M. N., Rutledge, C., Xin, H., Chopp, M., McCann, R., Rosene, D. L., Yang, Q., Zeldich, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.623673
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555684
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555720
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555696
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555693
Additional file 1 of Microglial amyloid beta clearance is driven by PIEZO1 channels
Jäntti, H., Sitnikova, V., Ishchenko, Y., Shakirzyanova, A., Giudice, L., Ugidos, I. F., Gómez‐Budia, M., Korvenlaita, N., Ohtonen, S., Belaya, I., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080821
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555714
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555717
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555687
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555690
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555702
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555681
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555672
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555708
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555675
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555678
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555699
Gu, D., Wang, L., Zhang, N., Wang, H., & Yu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26575418
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555723
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26555705
Metadata
- Authors
- Podleśny-Drabiniok, A., Marcora, E., & Goate, A. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Goate, Alison M.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 43
- Issue
- 12
- Pages
- 965-979
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC9080913
- OpenAlex
- W3095321129
- Cited by
- 211
- References
- 123
- Citations by year
- 2026: 22 · 2025: 37 · 2024: 60 · 2023: 35 · 2022: 33 · 2021: 24
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (U01 AG052411, RF1AG054011, U01AG058635)
- JPB Foundation
- Neurodegeneration Consortium
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- Alzheimer's disease, microglial phagocytosis, myeloid cells, genome-wide association study, endolysosomal system, debris removal, neurodegeneration, causal genes
- MeSH terms
- Alzheimer Disease, Humans, Phagocytosis, Microglia, Neurodegenerative Diseases, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review